Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT06171412
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Glu-COACH — BEHAVIORALpeer-mentoring support from a peer of the same cultural identity and access to a private social media group for all Black and Latinx teens
Study Details
This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.
Key Dates
- Start date
- May 21, 2024
- Status verified
- Jul 2025
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 38 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Glu-COACHThe experimental group will receive ESOC plus peer-mentoring support from a peer of the same cultural identity (Glu-COACH) and access to a private social media group for all Black and Latinx teens to improve the initiation and maintenance of CGM (Dexcom)
Primary Outcome Measure
Mean hours per week CGM worn [ Time Frame: 3 months and 6 months ]
Central Contacts
- Stuart A Weinzimer, MD877.925.3637
- Robin Whittemore, PhD, APRN, FAAN203-737-2351
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale Children's Diabetes Clinic | New Haven | Connecticut | 06520 | - |
Find similar trials in New Haven, CT
By condition
By specialty
By research site
Related Studies
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Baltimore, Maryland
- Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1DEnrolling By Invitation · University of Connecticut · Middletown, Connecticut
- T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 DiabetesRecruiting · Yale University · New Haven, Connecticut
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesPHASE1/PHASE2 · Recruiting · City of Hope Medical Center · San Francisco, California